Primary |
Product Used For Unknown Indication |
27.6% |
Drug Use For Unknown Indication |
17.7% |
Drug Abuse |
17.3% |
Pain |
10.1% |
Drug Diversion |
7.6% |
Back Pain |
5.4% |
Breakthrough Pain |
4.0% |
Fibromyalgia |
1.3% |
Back Disorder |
1.1% |
Completed Suicide |
1.1% |
Intervertebral Disc Protrusion |
0.9% |
Neck Pain |
0.9% |
Substance Abuse |
0.9% |
Arthralgia |
0.7% |
Constipation |
0.7% |
Exposure During Breast Feeding |
0.7% |
Pain In Extremity |
0.7% |
Adnexa Uteri Pain |
0.4% |
Alcohol Abuse |
0.4% |
Anxiety |
0.4% |
|
Overdose |
11.8% |
Drug Diversion |
9.6% |
Drug Toxicity |
9.6% |
Drug Abuse |
9.1% |
Drug Ineffective |
7.5% |
Wrong Technique In Drug Usage Process |
7.5% |
Drug Dependence |
6.4% |
Thrombotic Thrombocytopenic Purpura |
4.8% |
Unresponsive To Stimuli |
4.8% |
Drug Screen Positive |
3.7% |
Intentional Drug Misuse |
3.7% |
Toxicity To Various Agents |
3.7% |
Pulmonary Oedema |
3.2% |
Withdrawal Syndrome |
3.2% |
Thrombocytopenia |
2.7% |
Accidental Death |
2.1% |
Convulsion |
1.6% |
Death |
1.6% |
Drug Screen Negative |
1.6% |
Feeling Abnormal |
1.6% |
|
Secondary |
Pain |
22.2% |
Product Used For Unknown Indication |
20.8% |
Drug Use For Unknown Indication |
9.5% |
Breakthrough Pain |
8.7% |
Back Pain |
8.4% |
Drug Abuse |
5.5% |
Intervertebral Disc Protrusion |
2.9% |
Arthralgia |
2.8% |
Depression |
2.5% |
Neck Pain |
2.4% |
Rheumatoid Arthritis |
2.3% |
Fibromyalgia |
1.7% |
Burning Sensation |
1.5% |
Hip Arthroplasty |
1.5% |
Leg Amputation |
1.5% |
Spinal Disorder |
1.5% |
Anxiety |
1.4% |
Neuropathy Peripheral |
1.1% |
Pain In Extremity |
1.1% |
Hypertension |
1.0% |
|
Drug Toxicity |
12.2% |
Wrong Technique In Drug Usage Process |
10.7% |
Drug Abuse |
9.2% |
Overdose |
8.4% |
No Adverse Event |
5.3% |
Vomiting |
5.3% |
Weight Decreased |
5.3% |
Somnolence |
4.6% |
Cellulitis |
3.8% |
Death |
3.8% |
Diarrhoea |
3.8% |
Drug Ineffective |
3.8% |
Intentional Drug Misuse |
3.8% |
Pain |
3.8% |
Substance Abuse |
3.8% |
Paranoia |
3.1% |
Back Pain |
2.3% |
Drug Dependence |
2.3% |
Drug Screen Positive |
2.3% |
Hypoacusis |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
32.0% |
Pain |
20.1% |
Drug Use For Unknown Indication |
6.8% |
Back Pain |
5.9% |
Rheumatoid Arthritis |
4.3% |
Depression |
3.9% |
Breakthrough Pain |
3.2% |
Hypertension |
3.1% |
Anxiety |
2.8% |
Gastrooesophageal Reflux Disease |
2.4% |
Multiple Sclerosis |
2.4% |
Fibromyalgia |
2.0% |
Crohn's Disease |
1.9% |
Asthma |
1.5% |
Muscle Spasms |
1.4% |
Hepatitis C |
1.4% |
Diabetes Mellitus |
1.3% |
Insomnia |
1.3% |
Sleep Disorder |
1.3% |
Arthritis |
1.2% |
|
Drug Ineffective |
10.6% |
Vomiting |
9.9% |
Wrong Technique In Drug Usage Process |
9.9% |
Nausea |
7.3% |
Drug Prescribing Error |
6.6% |
Death |
4.6% |
Injection Site Pain |
4.6% |
Insomnia |
4.6% |
Medication Residue Present |
4.6% |
Pain |
4.0% |
Vision Blurred |
4.0% |
Weight Decreased |
4.0% |
Medication Error |
3.3% |
Pulmonary Embolism |
3.3% |
Somnolence |
3.3% |
Urticaria |
3.3% |
Weight Increased |
3.3% |
Withdrawal Syndrome |
3.3% |
Fatigue |
2.6% |
Flushing |
2.6% |
|
Interacting |
Arthritis |
14.3% |
Depression |
14.3% |
Hypertension |
14.3% |
Hypogonadism |
14.3% |
Pain |
14.3% |
Rheumatoid Arthritis |
14.3% |
Rhinitis Allergic |
14.3% |
|
Hepatic Congestion |
25.0% |
Pulmonary Congestion |
25.0% |
Toxicity To Various Agents |
25.0% |
Troponin Increased |
25.0% |
|